The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Microbot Medical reported over 100% growth in revenue and new customers for Q2 2026, announcing plans to expand its U.S. sales territories and enter international markets. The period also saw significant M&A activity, with BiomX signing a letter of intent to acquire an Israeli security infrastructure firm, and Stereotaxis completing its acquisition of robotic innovator Robocath. Additionally, IKS Health finalized its acquisition of TruBridge, a provider of EHR and revenue cycle management solutions.